CureVac N.V. (CVAC) EBITDA (2019 - 2025)
CureVac N.V. (CVAC) EBITDA from Mar 31, 2019 to Sep 30, 2025. The TTM CureVac N.V. (CVAC) EBITDA is -$115M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
CureVac N.V. (CVAC) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +6.45% |
| 5 Years TTM | +2.43% |
| All Time TTM | +6.24% |
Annual EBITDA change of CureVac N.V. (CVAC)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$115M | -153.15% |
| 2024 | $217M | -183.97% |
| 2023 | -$259M | +15.76% |
| 2022 | -$223M | -49.16% |
| 2021 | -$439M | +192.19% |
| 2020 | -$150M | +42.79% |
| 2019 | -$105M | +31.46% |
| 2018 | -$80M | N/A |
Comparison CureVac N.V. (CVAC) five years EBITDA CAGR with competitors
CureVac N.V. (CVAC) five years EBITDA CAGR is 2.44%.